Matches in Wikidata for { <http://www.wikidata.org/entity/Q65341445> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q65341445 description "clinical trial" @default.
- Q65341445 description "ensayu clínicu" @default.
- Q65341445 description "klinisch onderzoek" @default.
- Q65341445 description "клінічне випробування" @default.
- Q65341445 name "A Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy" @default.
- Q65341445 name "A Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy" @default.
- Q65341445 type Item @default.
- Q65341445 label "A Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy" @default.
- Q65341445 label "A Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy" @default.
- Q65341445 prefLabel "A Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy" @default.
- Q65341445 prefLabel "A Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy" @default.
- Q65341445 P1132 Q65341445-C0B60FB3-69BA-497C-B33B-D66C46CD2A8F @default.
- Q65341445 P1476 Q65341445-581BC063-F1DD-4277-A9E0-4297DEBC51C9 @default.
- Q65341445 P17 Q65341445-99137DC9-4CC6-4EFD-AE61-F9F299BF13DE @default.
- Q65341445 P2899 Q65341445-B2F5B1D9-7363-40C7-9FA6-D0B89670EAAB @default.
- Q65341445 P3098 Q65341445-B6702E9C-5896-400A-98D2-9C9C3C18D14D @default.
- Q65341445 P31 Q65341445-B42FDA9A-D08C-4255-B820-C622BB8EF421 @default.
- Q65341445 P580 Q65341445-4A4BE0AF-8087-4FEC-9BD6-12B05CA5AE07 @default.
- Q65341445 P582 Q65341445-346BD90F-5777-4870-A68C-270B9351A7BF @default.
- Q65341445 P6099 Q65341445-69C5FD40-7B9E-4E01-9682-19E6BE1E5BE0 @default.
- Q65341445 P8363 Q65341445-2B704EEB-C458-4C0C-8F09-BE0108E6ABA9 @default.
- Q65341445 P1132 "+463" @default.
- Q65341445 P1476 "A Phase 2, Randomized, Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy" @default.
- Q65341445 P17 Q30 @default.
- Q65341445 P2899 "+18" @default.
- Q65341445 P3098 "NCT02504580" @default.
- Q65341445 P31 Q30612 @default.
- Q65341445 P580 "2015-07-01T00:00:00Z" @default.
- Q65341445 P582 "2017-03-01T00:00:00Z" @default.
- Q65341445 P6099 Q42824440 @default.
- Q65341445 P8363 Q78089383 @default.